GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NFL Biosciences SA (XPAR:ALNFL) » Definitions » Interest Expense

NFL Biosciences (XPAR:ALNFL) Interest Expense : €-0.01 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is NFL Biosciences Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. NFL Biosciences's interest expense for the six months ended in Dec. 2023 was € -0.01 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.01 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. NFL Biosciences's Operating Income for the six months ended in Dec. 2023 was € -1.86 Mil. NFL Biosciences's Interest Expense for the six months ended in Dec. 2023 was € -0.01 Mil. NFL Biosciences did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


NFL Biosciences Interest Expense Historical Data

The historical data trend for NFL Biosciences's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NFL Biosciences Interest Expense Chart

NFL Biosciences Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Expense
Get a 7-Day Free Trial - - - - -0.01

NFL Biosciences Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Interest Expense Get a 7-Day Free Trial - -0.10 - - -0.01

NFL Biosciences Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NFL Biosciences  (XPAR:ALNFL) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

NFL Biosciences's Interest Expense for the six months ended in Dec. 2023 was €-0.01 Mil. Its Operating Income for the six months ended in Dec. 2023 was €-1.86 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was €0.00 Mil.

NFL Biosciences's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

NFL Biosciences did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


NFL Biosciences (XPAR:ALNFL) Business Description

Traded in Other Exchanges
Address
199 rue Helene Boucher, Castelnau-le-Lez, FRA, 34170
NFL Biosciences SA specializes in the research and development of medicines to combat tobacco addiction that use botanical and pharmaceutical agents. NFL-101 is company's core product, targeting smoking addiction. It is a clinically developed, botanical drug that contains an insignificant amount of nicotine and is composed of well characterized, natural tobacco leaf proteins.

NFL Biosciences (XPAR:ALNFL) Headlines

No Headlines